KRAS and neoplasm: We hypothesised that the upregulation of m6A-modified lncRNAs related to prognosis might have a hidden connection with the KRAS-BRAF-EGFR signalling pathway and induce tumour cell angiogenesis, cell proliferation, invasion and metastasis, enriching the targets for the treatment of CRC (Martinelli et al., 2020).